DR REDDYS LABORATORIES will participate in a Nomura investor meeting in Hyderabad on 25.09.2026, scheduled from 11:00 to 14:00 IST. Investors have a stated organizer, location, meeting format and time window for the management session, while the schedule remains subject to change for circumstances involving investors or the company.
Key Highlights
- The Nomura meeting is scheduled for 25.09.2026 from 11:00 to 14:00 IST.
- Hyderabad will host the in-person group meeting involving single institutions or investor groups.
- The schedule can change because of circumstances affecting investors or the company.
Management will participate in a Nomura investor meeting in Hyderabad on 25.09.2026, with the in-person session set for 11:00 to 14:00 IST.
Nomura Meeting Set for Hyderabad
Nomura is organizing the meeting, while Hyderabad is the listed location. The communication was also directed to those exchanges. K Randhir Singh signed on behalf of the company as Company Secretary, Compliance Officer & Head-CSR. The timetable may change because of circumstances involving investors or the company.
FAQs
Q: When is the DR REDDYS LABORATORIES investor meeting?
A: DR REDDYS LABORATORIES management is scheduled to meet investors on 25.09.2026 from 11:00 to 14:00 IST. The planned session will take place in Hyderabad.
Q: Who is organizing the DR REDDYS LABORATORIES investor meeting?
A: Nomura is organizing the investor meeting. The event is planned as an in-person group meeting involving single institutions or investor groups.
Q: Can the Nomura investor meeting schedule change?
A: Yes. The stated timetable remains subject to change because of circumstances affecting investors or DR REDDYS LABORATORIES.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.